Cardiac Events Tied to Certain Antibiotics

Macrolide use was also associated with a 31% increased risk of cardiovascular death, but not with an increase in the risk of all-cause death, noncardiovascular death, myocardial infarction, or stroke. http://www.medpagetoday.com/Cardiology/Arrhythmias/54705?xid=nl_mpt_DHE_2015-11-16&eun=g721819d0r Antibiotic macrolides US FDA-approved : Azithromycin - unique; does not inhibit CYP3A4 Clarithromycin Erythromycin Fidaxomicin Telithromycin